TRU-SENTIMENT · DeltaNeutral
ACAD Trading Analysis - 09/23/2026 11:09 AM — TRU-SENTIMENT
Options chain · Stock chart · Baseline chart
ACAD (Acadia Pharmaceuticals Inc.) at $25.46. True Sentiment Balanced, delta 40-60 call 41% / put 59%, call $1,900 vs put $2,700. RSI 20.7.
- Symbol
- ACAD
- Price
- $25.46
- Article bias (separate from True Sentiment)
- bearish
- Conviction
- medium
- Published
- 2026-09-23 11:09:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options):Overall options flow sentiment: Balanced
Call dollar volume: $1,900
Put dollar volume: $2,700
The balanced sentiment suggests that there is no clear directional bias in the options market.
Key Statistics: ACAD
Fundamental Snapshot
Valuation
| P/E (Trailing) | 11.84 |
| P/E (Forward) | N/A |
| PEG Ratio | N/A |
| Price/Book | 6.96 |
Profitability
| EPS (Trailing) | $2.23 |
| EPS (Forward) | N/A |
| ROE | 29.12% |
| Net Margin | 33.42% |
Financial Health
| Revenue (TTM) | $1.14B |
| Debt/Equity | 0.33 |
| Free Cash Flow | N/A |
| Rev Growth | N/A |
Analyst Consensus
📈 Analysis
News Headlines & Context:
Recent news headlines for ACAD include:
- ACADIA Pharmaceuticals announces FDA approval for a new treatment.
- The company reports increased sales for its flagship medication.
- Analysts upgrade ACAD's rating due to strong quarterly performance.
These headlines suggest a positive outlook for ACAD, with potential catalysts for growth. However, it's essential to analyze the technical and fundamental data to understand the current market position and potential future movements.
Fundamental Analysis:
Based on the provided fundamentals:
- Revenue: $1,138,643,000
- Trailing EPS: $2.23
- Trailing P/E: 11.84
- Debt/Equity: 0.33
- ROE: 29.12%
The company shows a strong revenue figure, a reasonable P/E ratio, and a healthy debt-to-equity ratio. The ROE indicates efficient use of shareholder equity. However, without the revenue growth rate and forward EPS, it's challenging to assess the company's future growth prospects.
Current Market Position:
Current price: $25.53
Recent price action shows a decline, with the stock reaching a 30-day low of $25.51.
Key support levels: $25.51 (30-day low), $25.69 (Bollinger Band lower bound)
Key resistance levels: $27.84 (50-day SMA), $29.99 (Bollinger Band upper bound)
Technical Analysis:
Technical Indicators
The RSI indicates oversold conditions, while the MACD shows a bearish signal. The 50-day SMA is above the current price, indicating a downtrend.
True Sentiment Analysis (Delta 40-60 Options):
Overall options flow sentiment: Balanced
Call dollar volume: $1,900
Put dollar volume: $2,700
The balanced sentiment suggests that there is no clear directional bias in the options market.